Main Conference Day One


Eduardo Zaborowski, Ph.D

Senior Director, Information and Research Technologies
The Jackson Laboratory

Peter Gates

Director Data Architecture Translational Informatics
Janssen, Pharmaceutical Companies of Johnson and Johnson

9:45 AM - 10:30 AM How Artificial Intelligence and Machine Learning is Shifting Pharma R&D—for the Better

11:15 AM - 12:00 PM Coping with Vendorlock: Building Interoperability and Data Standardization from the Ground-Up

12:00 PM - 12:45 PM Breaking into the Pre-Competitive Space: The Pistoia Alliance , Pre-Competitive Activities, and Initiating Cultural Change

Carmen Nitsche, Executive Director Business Development North America, Pistoia Alliance


Carmen Nitsche

Executive Director Business Development North America
Pistoia Alliance

1:45 PM - 2:30 PM Merck’s Strategy to Streamline Drug Design and Create the Best Possible Molecules for Clinical Evaluation

Scott Harrison, Associate Principal Scientist, Cheminformatics, Merck


Scott Harrison

Associate Principal Scientist, Cheminformatics

2:30 PM - 3:15 PM Data Visualization as part of Merck’s Compound Design Cycle Enhancement Strategy to Streamline Drug Design, Synthesis, and Analysis

Anthony Donofrio, Senior Scientist, HTE and Lead Discovery Capabilities, Merck Research Laboratories


Anthony Donofrio

Senior Scientist, HTE and Lead Discovery Capabilities
Merck Research Laboratories

3:45 PM - 4:30 PM Supporting Observational Medicine with a Digital Patient Infrastructure to Advance Realworld Data Collection Efforts

Robert J Boland, Associate Director, Emerging Science & Innovation, Johnson & Johnson


Robert J Boland

Associate Director, Emerging Science & Innovation
Johnson & Johnson

4:30 PM - 5:15 PM CASE STUDY: How BMS Is Saving 11,000 Hours Annually by Orchestrating the Discovery Research Environment and Developing An Increased Sensitivity to R&D Needs

Viral Vyas, Associate Director, R&D IT, Bristol-Myers Squibb


Viral Vyas

Associate Director, R&D IT
Bristol-Myers Squibb

1:45 PM - 2:30 PM Eliminating Siloes Surrounding Tech-Transfer when Moving to Manufacturing

2:30 PM - 3:15 PM Exploring FDA’s Guidance on Quality Metrics and it’s Impact on Your Business

3:45 PM - 4:30 PM Integrating Elements of Manufacturing into Research and Clinical

4:30 PM - 5:15 PM Streamlining IT Resources and Systems between R&D and Quality Labs